0.00Open0.06Pre Close0 Volume25 Open Interest95.00Strike Price0.00Turnover420.19%IV22.97%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.0215Delta0.0066Gamma1288.42Leverage Ratio-0.8684Theta0.0000Rho27.70Eff Leverage0.0010Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet